LGND
Ligand Pharmaceuticals Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−0.45%
vs ±7.5% implied · ×0.06
shaded = implied · ▲▼ = realized
Ligand Pharmaceuticals Inc
319.37
No thesis.
Fund move
Fund move
No implied move.
No implied move.
Expected move
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $980.2M | 13.65% | +4.70% | |
| 2 | InvescoInvesco | $379.8M | 5.29% | +45.90% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $359.8M | 5.01% | +3.46% | |
| 4 | Jupiter TopcoJupiter Topco | $328.9M | 4.58% | — | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $275.3M | 3.83% | +2.70% | |
| 6 | State StreetState Streetindex-like | $261.3M | 3.64% | +6.12% | |
| 7 | FMRFMR | $241.1M | 3.36% | +27.96% | |
| 8 | Franklin ResourcesFranklin Resources | $237.7M | 3.31% | +31.21% | |
| 9 | Congress Asset ManagementCongress | $208.6M | 2.91% | +30.77% | |
| 10 | Geode Capital ManagementGeodeindex-like | $186.2M | 2.59% | +5.38% | |
| 11 | Delaware Management HoldingsDelaware | $179.7M | 2.50% | −0.86% | |
| 12 | Chicago CapitalChicago Capital | $174.9M | 2.44% | −1.47% | |
| 13 | Stephens Investment Management GroupStephens | $150.3M | 2.09% | −3.85% | |
| 14 | Dimensional Fund AdvisorsDimensional | $135.7M | 1.89% | +0.96% | |
| 15 | Massachusetts Financial ServicesMassachusetts Financial Services | $118.8M | 1.65% | −8.69% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $102.2M | 1.42% | −15.18% | |
| 17 | Loomis Sayles & Co L PLoomis Sayles & Co L P | $92.2M | 1.28% | −17.38% | |
| 18 | Rice Hall James & AssociatesRice Hall James & | $85.4M | 1.19% | −4.77% | |
| 19 | Ranger Investment ManagementRanger | $81.4M | 1.13% | −3.86% | |
| 20 | Northern TrustNorthern Trustindex-like | $81.4M | 1.13% | +1.27% | |
| 21 | Victory Capital ManagementVictory | $80.2M | 1.12% | −16.31% | |
| 22 | Deutsche Bank AG\Deutsche Bank AG\ | $78.9M | 1.10% | −18.46% | |
| 23 | Neuberger Berman GroupNeuberger Berman | $78.5M | 1.09% | +16887.35% | |
| 24 | GW&K Investment ManagementGW&K | $78.0M | 1.09% | +65.14% | |
| 25 | UBS Asset Management AmericasUBS Asset Management Americas | $66.5M | 0.93% | −1.16% |
420 managers report $7.2B of Ligand Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 39 of them hold 80% of it; BlackRock is largest at 13.65%.